SDHB deficiency silences ABCB1 expression and confers therapeutic vulnerability across multiple cancer types

SUMOylation is a Therapeutic Vulnerability in High-risk Neuroblastoma
A. Kukkula, S. Sriraman, V. Virtanen +5
bioRxiv5 Sep 2026PreprintAll rights reservedFull textOncologybioRxiv
Nuclear Cathepsin L Remodels the Replication Machinery to Create a Therapeutic Vulnerability in Ovarian Cancer
P. Thirusangu, L. Jin, S. Rao +9
bioRxiv2 Sep 2026PreprintAll rights reservedFull textOncologybioRxiv
Choline Kinase Alpha Inhibition is a Mutation Agnostic Therapeutic Vulnerability in Clonal Hematopoiesis
B. J. Gheller, O. Mitchell, M. Quach +11
bioRxiv26 Oct 2026PreprintAll rights reservedFull textOncologybioRxivPMC
DEGS1-mTORC1-driven lipid metabolic reprogramming fuels rhabdomyosarcoma progression and unveils a therapeutic vulnerability
Priya D Gopal Krishnan, Kah Yong Goh, Kai Hung Chen +13
Nature Communications27 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
Deficiency of the Lipoprotein Lipase Pathway Modifies the Phenotypic Expression of Genetically Determined Lipoprotein(a)
Sotirios Tsimikas, Xiaohong Yang, Elaine Waldman +3
Journal of Lipid Research1 Oct 2026Peer-reviewedCC BY 4.0Cardiovascular medicineCrossref

Cite

BibTeX

@misc{guo2026sdhb,
  title = {{SDHB deficiency silences ABCB1 expression and confers therapeutic vulnerability across multiple cancer types}},
  author = {Q. Guo and A. Zhen and B. E. Howitt and J. P. Annes},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.29.761968},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.29.761968v1},
}

RIS

TY  - UNPB
TI  - SDHB deficiency silences ABCB1 expression and confers therapeutic vulnerability across multiple cancer types
AU  - Q. Guo
AU  - A. Zhen
AU  - B. E. Howitt
AU  - J. P. Annes
PY  - 2026
DA  - 2026/10/29
PB  - bioRxiv
DO  - 10.64898/2026.10.29.761968
UR  - https://www.biorxiv.org/content/10.64898/2026.10.29.761968v1
ER  -

Related

Cite